The life sciences sector in London is seeing significant growth, further cementing the city’s position as a leading hub for scientific research and development in both the UK and Europe. With increasing demand for specialized lab spaces, particularly following recent global health challenges, the sector has expanded, driving investment and innovation. The construction of Europe’s tallest commercial lab at Canary Wharf, One North Quay, underscores the continued rise of the life sciences industry in the city.
Designed by leading architectural firm KPF, One North Quay will rise 23 stories, offering 823,000 square feet of state-of-the-art lab space. This vertical science campus is set to become a landmark not only for its height but for its advanced technological and sustainable design. The project is led by Canary Wharf Contractors, with Kilnbridge managing the complex concrete works.
The need for lab spaces in London, particularly those accommodating up to level 3 laboratory containment, has far outpaced supply. Up to 60% of One North Quay will be dedicated to wet laboratory space, a facility crucial for cutting-edge research in fields like biotechnology, pharmaceuticals, and advanced medical treatments.
The rise of buildings like One North Quay is a response to the increasing demand for life sciences infrastructure. As London grows as a global leader in scientific innovation, investors are recognizing the importance of providing spaces that facilitate this work. The city has become an attractive destination for life sciences companies seeking specialized facilities that allow them to conduct high-level research and development.
Shobi Khan, CEO of Canary Wharf Group, highlighted the significance of the development, stating, “The vertical campus will set a new precedent in terms of scale, technology, and sustainability, and forms part of Canary Wharf’s ongoing 3.0 strategy in creating a vibrant urban mixed-use community which has 16.5 acres of green spaces and waterside living, over 350 shops, restaurants and bars as well as a growing leisure and amenities offering and a year-round events calendar.”
This new construction is part of the larger trend toward creating purpose-built lab spaces that not only serve research purposes but are also designed with sustainability in mind. One North Quay will be a model of high-performance, energy-efficient design, featuring an airtight, insulated building fabric and an optimized façade to reduce carbon emissions. These sustainable elements are essential as the life sciences sector itself embraces environmentally responsible practices in both research and infrastructure development.
The project’s design emphasizes collaboration and innovation, key drivers of the life sciences sector’s growth. One North Quay will feature over 20,000 square feet of amenities and shared communal spaces, including three dedicated “maker spaces” for collaborative work and experimentation. These shared areas are designed to create a community atmosphere within the building, encouraging the exchange of ideas and fostering a culture of innovation.
The growing demand for spaces like One North Quay reflects the broader expansion of the life sciences sector, both in London and globally. As scientific breakthroughs continue to capture the world’s attention, the need for modern, flexible, and high-tech laboratory facilities has never been greater. The construction of Europe’s tallest lab tower is a bold statement of the sector’s future in London, confirming the city’s status as a critical player in global health, research, and innovation.
The life sciences sector is no longer a niche market – it’s a booming industry that is reshaping the real estate landscape. With investments pouring into life sciences infrastructure and companies vying for the best laboratory spaces, buildings like One North Quay are proof that the demand is here to stay.
